Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
International Journal of Nanomedicine|January 9, 2014
First line treatment of advanced non-small-cell lung cancer - specific focus on albumin bound paclitaxelNeha Gupta, Hassan Hatoum, Grace K Dy
International Journal of Molecular Sciences|February 2, 2021
Serotonin Pathway in CancerPragathi Balakrishna, Sagila George, Hassan Hatoum, et al.
Anticancer Research|February 5, 2020
Predictors of Outcome in Patients With Fibrolamellar Carcinoma: Analysis of the National Cancer DatabaseHussein A Assi, Sarbajit Mukherjee, Michael Machiorlatti, et al.
Frontiers in Oncology|January 30, 2023
The evolving role of radiation in pancreatic cancerMidhun Malla, Fatemeh Fekrmandi, Nadia Malik, et al.
The Oncologist|February 12, 2020
Surgery Versus Surveillance for Well-Differentiated, Nonfunctional Pancreatic Neuroendocrine Tumors: An 11-Year Analysis of the National Cancer DatabaseHussein A Assi, Sarbajit Mukherjee, Pamela L Kunz, et al.
Cardiology|August 19, 2011
Usefulness of red cell distribution width in predicting all-cause long-term mortality after non-ST-elevation myocardial infarctionBasem Azab, Estelle Torbey, Hassan Hatoum, et al.
Clinical Medicine Insights. Oncology|May 24, 2012
Small cell lung cancer doubling time and its effect on clinical presentation: a concise reviewKassem Harris, Inga Khachaturova, Basem Azab, et al.
Future Oncology (London, England)|May 4, 2026
Impact of UGT1A1*28 polymorphism in patients with metastatic pancreatic ductal adenocarcinoma treated with NALIRIFOX in the NAPOLI 3 trialMaen Abdelrahim, Gazala Khan, Hassan Hatoum, et al.
The Oncologist|July 25, 2024
Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2Hassan Hatoum, Alexander Rosemurgy, J Augusto Bastidas, et al.
Cancer Medicine|April 9, 2025
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II StudySarbajit Mukherjee, Yu Fujiwara, Christos Fountzilas, et al.
Pageof 2